EMERGE HEALTH INTERNATIONAL INC
CIK:0000032567|SEC Filings
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2018 |
|
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||
| Gross sales | $ 0 | $ 1,938,222 |
| Cost of sales | 0 | 1,304,551 |
| Gross profit | 0 | 633,671 |
| Operating expenses | 91,217 | 1,087,963 |
| Research and development | 2,235,593 | 6,375 |
| Total operating expenses | 2,326,810 | 1,094,338 |
| Net loss from operations | (2,326,810) | (460,667) |
| Other Income (expense) | ||
| Interest | (27,706) | (25,635) |
| Total Other Income (expense) | (27,706) | 4,170 |
| Net income (loss) before taxes | (2,354,516) | (21,465) |
| Income taxes | 0 | 0 |
| Net Loss | (2,354,516) | (482,132) |
| Loss from discontinued operations | (1,462,790) | 0 |
| Net Loss | $ (3,817,306) | $ (482,132) |
| Loss from operations | ||
| Basic loss per share | $ (0.15) | $ 0.03 |
| Weighted number of shares outstanding | 17,797,685 | 17,766,647 |
| Loss from discontinued operations | ||
| Basic loss per share | $ 0.02 | $ 0.00 |
| Weighted number of shares outstanding | 17,797,685 | 17,766,647 |